Back to Search
Start Over
Isoflurane lowers the cerebral metabolic rate of oxygen and prevents hypoxia during cortical spreading depolarization in vitro : An integrative experimental and modeling study.
- Source :
-
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism [J Cereb Blood Flow Metab] 2024 Jun; Vol. 44 (6), pp. 1000-1012. Date of Electronic Publication: 2023 Dec 23. - Publication Year :
- 2024
-
Abstract
- Cortical spreading depolarization (SD) imposes a massive increase in energy demand and therefore evolves as a target for treatment following acute brain injuries. Anesthetics are empirically used to reduce energy metabolism in critical brain conditions, yet their effect on metabolism during SD remains largely unknown. We investigated oxidative metabolism during SD in brain slices from Wistar rats. Extracellular potassium ([K <superscript>+</superscript> ] <subscript>o</subscript> ), local field potential and partial tissue oxygen pressure (p <subscript>ti</subscript> O <subscript>2</subscript> ) were measured simultaneously. The cerebral metabolic rate of oxygen (CMRO <subscript>2</subscript> ) was calculated using a reaction-diffusion model. By that, we tested the effect of clinically relevant concentrations of isoflurane on CMRO <subscript>2</subscript> during SD and modeled tissue oxygenation for different capillary pO <subscript>2</subscript> values. During SD, CMRO <subscript>2</subscript> increased 2.7-fold, resulting in transient hypoxia in the slice core. Isoflurane decreased CMRO <subscript>2</subscript> , reduced peak [K <superscript>+</superscript> ] <subscript>o</subscript> , and prolonged [K <superscript>+</superscript> ] <subscript>o</subscript> clearance, which indicates reduced synaptic transmission and sodium-potassium ATPase inhibition. Modeling tissue oxygenation during SD illustrates the need for increased capillary pO <subscript>2</subscript> levels to prevent hypoxia. In the absence thereof, isoflurane could improve tissue oxygenation by lowering CMRO <subscript>2</subscript> . Therefore, isoflurane is a promising candidate for pre-clinical studies on neuronal survival in conditions involving SD.<br />Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Subjects :
- Animals
Rats
Anesthetics, Inhalation pharmacology
Male
Hypoxia metabolism
Potassium metabolism
Oxygen Consumption drug effects
Brain metabolism
Brain drug effects
Hypoxia, Brain metabolism
Hypoxia, Brain drug therapy
Isoflurane pharmacology
Rats, Wistar
Cortical Spreading Depression drug effects
Cortical Spreading Depression physiology
Oxygen metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1559-7016
- Volume :
- 44
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
- Publication Type :
- Academic Journal
- Accession number :
- 38140913
- Full Text :
- https://doi.org/10.1177/0271678X231222306